PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 25.444K |
Day Range | - - - |
52 Wk Range | 1.920 - 3.230 |
Market Cap | $18.090M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.58% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PharmaCyte Biotech (NASDAQ: PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Dominari Holdings (NASDAQ:DOMH) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for PharmaCyte Biotech (NASDAQ: PMCB) was reported by HC Wainwright & Co. on Monday, November 8, 2021. The analyst firm set a price target for 0.00 expecting PMCB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $2.14 last updated April 22, 2024 at 6:30 PM EDT.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech’s Q3 earnings are confirmed for Monday, March 18, 2024.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.